logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Ulcerative Colitis

    FiltersReset Filters
    16 results

    • cyltezo

      (adalimumab-adbm)
      Boehringer Ingelheim Pharmaceuticals, Inc.
      Usage: CYLTEZO is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients aged 2 and older.

    • hadlima

      (adalimumab-bwwd)
      Organon LLC
      Usage: HADLIMA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and/or pediatric patients. It can be used alone or with other therapies.

    • inflectra

      (infliximab-dyyb)
      Pfizer Laboratories Div Pfizer Inc
      Usage: INFLECTRA is indicated for treating moderately to severely active Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis in adults and pediatric patients aged 6 and older, particularly in cases unresponsive to conventional therapies.

    • methylprednisolone

      (METHYLPREDNISOLONE)
      Epic Pharma,LLC
      Usage: Methylprednisolone tablets are indicated for various conditions, including endocrine and rheumatic disorders, allergic states, dermatologic diseases, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and acute nervous system disorders, providing symptomatic relief or maintenance therapy.

    • methylprednisolone acetate

      (Methylprednisolone acetate)
      Amneal Pharmaceuticals LLC
      Usage: Methylprednisolone acetate injectable suspension is indicated for intramuscular, intra-articular, or intralesional administration to treat severe allergic conditions, dermatologic diseases, endocrine disorders, hematologic disorders, and various respiratory and rheumatic diseases, as well as for palliative care in neoplastic diseases and specific ophthalmic and renal conditions.

    • methylprednisolone sodium succinate

      (Methylprednisolone)
      Amneal Pharmaceuticals LLC
      Usage: Methylprednisolone sodium succinate is indicated for intravenous or intramuscular administration in severe allergic conditions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, neurological conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders, especially when oral therapy is not feasible.

    • omvoh

      (mirikizumab-mrkz)
      Eli Lilly and Company
      Usage: OMVOH is indicated for treating moderately to severely active ulcerative colitis and moderately to severely active Crohn's disease in adults.

    • rayos

      (prednisone)
      Horizon Therapeutics USA, Inc.
      Usage: RAYOS is indicated for severe allergic conditions, various dermatologic and endocrine diseases, gastrointestinal disorders (like Crohn's and ulcerative colitis), hematologic issues, neoplasms, nervous system conditions (such as multiple sclerosis), certain ophthalmic diseases, organ transplant rejection, pulmonary disorders, renal conditions, rheumatologic ailments, and specific infectious diseases.

    • simlandi

      (adalimumab-ryvk)
      Teva Pharmaceuticals USA, Inc.
      Usage: SIMLANDI is indicated for treating various inflammatory conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, either alone or in combination with other therapies.

    • simponi

      (golimumab)
      Janssen Biotech, Inc.
      Usage: SIMPONI is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis (with methotrexate), active psoriatic arthritis (alone or with methotrexate), active ankylosing spondylitis, and moderately to severely active ulcerative colitis in patients with corticosteroid dependence or inadequate response to previous therapies.